Gyudong Kim

Gyudong Kim

Auto-generated profile, based on publicly available information

Gyudong Kim

College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 61186, Korea

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JTJonathan E. Tsang
Jonathan E. Tsang
LULorenz M. Urner
Lorenz M. Urner
GKGyudong Kim
Gyudong Kim
KCKingsley Chow
Kingsley Chow
LBLynn Baufeld
Lynn Baufeld
DNDavid A. Nathanson
David A. Nathanson

23 October 2014 in Organic Letters
Verified
Journal Article
Closed access
PSPramod K. Sahu
Pramod K. Sahu
GKGyudong Kim
Gyudong Kim
JYJinha Yu
Jinha Yu
JAJi Yoon Ahn
Ji Yoon Ahn
JSJayoung Song
Jayoung Song
LJLak Shin Jeong
Lak Shin Jeong

17 August 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
ASAnna Shiriaeva
Anna Shiriaeva
DPDaejin Park
Daejin Park
GKGyudong Kim
Gyudong Kim
YLYOONJI LEE
YOONJI LEE
XHXiyan Hou
Xiyan Hou
VCVadim Cherezov
Vadim Cherezov
Modulators of the G protein-coupled A2A adenosine receptor (A2AAR) have been considered promising agents to treat Parkinson's disease, inflammation, cancer, and central nervous system disorders. Herein, we demonstrate that a thiophene modification at the C8 position in the common adenine scaffold converted an A2AAR agonist into an antagonist. We synthesized and characterized a novel A2AAR antagonist, 2 (LJ-4517), with Ki = 18.3 nM. X-ray crystallographic structures of 2 in complex with two thermostabilized A2AAR constructs were solved at 2.05 and 2.80 Å resolutions. In contrast to A2AAR agonists, which simultaneously interact with both Ser2777.42 and His2787.43, 2 only transiently contacts His2787.43, which can be direct or water-mediated. The n-hexynyl group of 2 extends into an A2AAR exosite. Structural analysis revealed that the introduced thiophene modification restricted receptor conformational rearrangements required for subsequent activation. This approach can expand the repertoire of adenosine receptor antagonists that can be designed based on available agonist scaffolds.

13 October 2017 in Organic Letters
Verified
Journal Article
Closed access
GKGyudong Kim
Gyudong Kim
JYJi-Seong Yoon
Ji-Seong Yoon
DJDnyandev B. Jarhad
Dnyandev B. Jarhad
YSYoung Sup Shin
Young Sup Shin
MMMahesh S. Majik
Mahesh S. Majik
LJLak Shin Jeong
Lak Shin Jeong

8 September 2015 in Organic Letters
Verified
Journal Article
Closed access
GKGyudong Kim
Gyudong Kim
YCYoojin Choi
Yoojin Choi
PSPramod K. Sahu
Pramod K. Sahu
JYJinha Yu
Jinha Yu
SQShuhao Qu
Shuhao Qu
LJLak Shin Jeong
Lak Shin Jeong

17 June 2022 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MNMai Nguyen
Mai Nguyen
SASeungchan An
Seungchan An
YNYen Nguyen
Yen Nguyen
YHYoung Eum Hyun
Young Eum Hyun
HCHongseok Choi
Hongseok Choi
LJLak Shin Jeong
Lak Shin Jeong